1. Developing New Drugs for Diabetes and Cardiometabolic Disorders

   • Andrew J. Krentz
   • Linda Morrow
   • Marcus Hompesch

   Editorial 06 January 2012 Pages: 1709 - 1711

2. Will Abuse-Deterrent Formulations of Opioid Analgesics Be Successful in Achieving Their Purpose?

   • Bernard Bannwarth

   Current Opinion 06 January 2012 Pages: 1713 - 1723

3. Polymorphisms of Estrogen Receptors and Risk of Depression

   • Joanne Ryan
   • Marie-Laure Ancelin

   Leading Article 06 January 2013 Pages: 1725 - 1738

   

4. New Oral Anticoagulants

   • Birgitte Klindt Poulsen
   • Erik Lerkevang Grove
   • Steen Elkjaer Husted

   Review Article 06 January 2012 Pages: 1739 - 1753

   

5. Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients

   • Ida Ehlers Albertsen
   • Torben Bjerregaard Larsen
   • Gregory Y. H. Lip

   Systematic Review 06 January 2012 Pages: 1755 - 1764

   

6. Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)

   • Paul L. McCormack

   Adis Drug Evaluation 06 January 2012 Pages: 1765 - 1791

   

7. Linagliptin

   • Emma D. Deeks

   Adis Drug Evaluation 06 January 2012 Pages: 1793 - 1824